1.  Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.

2.  Maeda H,Wu J, Sawa T, MatsumuraY, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000; 65: 271-84.

3.  Zamboni WC. Liposomal, nanoparticle, and conjugated formulations of anticancer agents. Clin Cancer Res 2005; 11: 8230-34.

4.  Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002; 2: 750-63

5.  Aboody KS, Najbauer J, Danks MK. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Therapy 2008; 15: 739-752.

6.  Vaziri H, Dragowska W, Allsopp RC, et al. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci 1994; 91: 9857-9860.

7.  Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.

8.  Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult ?broblast cultures by de?ned factors. Cell 2006; 126: 663-76.

9.  Yu J, et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells. Science 2007; 318(5858): 1917-20

10.  Joo SY, Kim JS. Enhancement of gene transfer to cervical cancer cells using transferrin-conjugated liposome. Drug Dev Ind Pharm 2002; 28: 1023-1031.

11.  Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97: 12846-12851.

12.  Dwyer RM, Potter-Beirne SM, Harrington Ka, et al. Monocyte Chemotactic Protein-1Secreted by Primary Breast Tumors Stimulates Migration of Mesenchymal Stem Cells. Human Cancer Biology 2007; 13(17): 5020-5027.

13.  Pereboeva L, Komarova S, Mikheeva G, Krasnykh V, Curiel DT. Approaches to utilize mesenchymal progenitor cells as cellular vehicles. Stem Cells 2003; 21: 389-404.

14.  Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.

15.  Belmadani A, Tran PB, Ren D, Miller RJ. Chemokines Regulate theMigration of Neural Progenitors to Sites of Neuroinflammation. Journal of Neuroscience 2006; 16(12): 3182-3191.

16.  Sun L, Lee J, Fine HA. Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J Clin Invest 2004; 113: 1364-1374

17.  Heese O, Disko A, Zirkel D, Westphal M, Lamszus K. Neural stem cell migration toward gliomas in vitro. Neuro Oncol 2005; 7: 476-484.

18.   Francois S, Bensidhoum M, Mouiseddine M, et al. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells 2006; 24: 1020-29.

19.  Najbauer J, Danks MK, Schmidt NO, Kim SU, Aboody KS. Neural stem cell-mediated therapy of primary and metastatic solid tumors. In: Bertolotti R, Ozawa K (eds). Progress in Gene Therapy, Autologous and Cancer Stem Cell Gene Therapy. World Scientific: Singapore, 2007.

20.  Ozawa CR, Springer ML, Blau HM. A novel means of drug delivery: myoblast-mediated gene therapy and regulatable retroviral vectors. Annu Rev Pharmacol Toxicol 2000; 40: 295-317.

21.  Herrlinger U, Jacobs A, Quinones A, Woiciechowsky C, Sena-Esteves M, Rainov NG et al. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma. Hum Gene Ther 2000; 11: 1429-1438.

22. Ramezani A, Hawley TS, Hawley RG. Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator. Blood 2003; 101: 4717-4724.

23.  Danks MK, Yoon KJ, Bush RA, Remack JS,Wierdl M, Tsurkan L et al. Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated
neuroblastoma. Cancer Res 2007; 67: 22-25.

24.  Kim SK, Kim SU, Park IH, Bang JH, Aboody KS, Wang KC et al. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to
tumor regression. Clin Cancer Res 2006; 12: 5550-5556.

25.  Shimato S, Natsume A, Takeuchi H,Wakabayashi T, Fujii M, Ito M et al. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma. Gene
Therapy 2007; 14: 1132-1142

26.  Houghton PJ, Santana VM. Clinical trials using irinotecan. J Pediatr Hematol Oncol 2002; 24: 84-85.

27.  Pollack IF, Erff M, Ashkenazi A. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Clin Cancer Res 2001; 7: 1362-1369

28.  Kim SK, Cargioli TG, Machluf M, Yang W, Sun Y, Al-Hashem R et al. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res 2005; 11: 5965-5970.

29.  Benedetti S, Pirola B, Pollo B, et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 2000; 6: 447-50.

30.  Tang Y, Shah K, Messerli SM, Snyder E, Breakfield X, Weissleder R. In vivo tracking of neural progenitor cell migration to glioblastomas. Hum Gene Ther 2003; 14: 1247-54.

31.  Shah K, Hingtgen S, Kasmieh R, et al. Bimodal Viral Vectors and In Vivo Imaging Reveal the Fate of Human Neural Stem Cells in Experimental Glioma Model. Journal of Neuroscience 2008; 28(17): 4406-4413. 

32.  Modo M, Cash D, Mellodew K, et al. Tracking Transplanted Stem Cell Migration Using Bifunctional, Contrast Agent-Enhanced, Magnetic Resonance Imaging. NeuroImage 2002; 17: 803-811.

33.  Hori J, Ng TF, Shatos M, Klassen H, Streilein JW, Young MJ. Neural progenitor cells lack immunogenicity and resist destruction as allografts. Ocul Immunol Inflamm 2007; 15: 261-273

34.  Shah K, Bureau E, Kim D, et al. Glioma Therapy and Real-Time Imaging of Neural Precursor Cell Migration and Tumor Regression. Ann Neurol 2005; 57: 34-41.

35.  Corsten MF, Shah K. Therapeutic stem-cells for cancer treatment: hopes and
hurdles in tactical warfare. Lancer Oncol 2008; 9: 376-84.



.